As of 13 Sept 2026, Aspira Pathlab & Diagnostics Ltd share price is ₹95.00. The stock opened at ₹95.00 and had closed at ₹94.56 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹49.00 and a high of ₹135.88. In terms of performance, Aspira Pathlab & Diagnostics Ltd share price has increased by 57.91% over the past six months and has increased by 49.61% over the last year.
Aspira Pathlab Stock Price Chart
Aspira Pathlab & Diagnostics Ltd Overview
About Aspira Pathlab
Aspira Pathlab & Diagnostics engaged in the business of running, owning, managing and administering Diagnostics Centres.
Aspira Pathlab & Diagnostics Ltd Historical Performance
Aspira Pathlab & Diagnostics Ltd Fundamentals
Aspira Pathlab & Diagnostics Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 25.50 | 22.39 | 13.62 | 14.78 | 19.64 |
| EBITDA | 1.98 | 3.91 | -0.76 | 1.92 | 6.47 |
| Net Profit | 0.05 | 2.07 | -2.67 | -0.09 | 4.46 |
| EPS | 0.05 | 2.01 | -2.60 | -0.09 | 4.33 |
Aspira Pathlab & Diagnostics Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 94.41 |
| Resistance 1 (R1) | 94.86 |
| Pivot Point | 94.71 |
Aspira Pathlab & Diagnostics Ltd Key Leadership Details
Last Updated: Mar 2025
| Name | Position |
|---|---|
| Haseeb A Drabu | Chairman |
| Pankaj Jashwant Shah | Managing Director & Chief Executive Officer |
| Nikunj Mange | Managing Director |
Aspira Pathlab & Diagnostics Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Apollo Hospitals Enterprise LtdAPOLLOHOSP | ₹8,836.00-0.72% | ₹1,10,231.07 | 59.08 | 20.48% |
| Max Healthcare Institute LtdMAXHEALTH | ₹1,037.70-0.09% | ₹1,02,534.79 | 72.27 | 13.42% |
| Fortis Healthcare LtdFORTIS | ₹887.80-1.62% | ₹68,746.49 | 70.10 | 10.53% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Aspira Pathlab & Diagnostics Ltd today is ₹95.00 on NSE and ₹95.00 on BSE.
- The 52-week high of Aspira Pathlab & Diagnostics Ltd is ₹135.88, while the 52-week low is ₹49.00.
- The current market capitalisation of Aspira Pathlab & Diagnostics Ltd is approximately ₹98 crore.
- The P/E (Price-to-Earnings) ratio of Aspira Pathlab & Diagnostics Ltd is 24.46. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Aspira Pathlab & Diagnostics Ltd is 8.11. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Aspira Pathlab & Diagnostics Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for Aspira Pathlab on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Aspira Pathlab & Diagnostics Ltd has delivered a return of approximately 155.17%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Aspira Pathlab & Diagnostics Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 46.58% promoters, 0.00% FIIs, 0.00% DIIs, and 40.70% public shareholders.

